Page 1 of 8Free preview · 1–5

About this document

Clinical Payment and Coding Policy CPCPLAB003, version 1.0, approved September 13, 2024, and effective January 1, 2025, for Blue Cross and Blue Shield of Texas only. Defines reimbursement criteria for 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum testing, including qualifying conditions, supplementation monitoring, and nonreimbursable screening. Repeat testing for documented deficiency may be reimbursable at least 12 weeks after supplementation begins, limited to two instances per year until the therapeutic goal is achieved, with annual testing thereafter. Lists procedure codes 82306, 82652, and 0038U, supporting references, and policy update history. Plan documents and provider contracts govern in the event of a conflict.

Free preview text

The first 5 pages, shown as text so search engines and readers can find this document.

Page 1

1 If a conflict arises between a Clinical Payment and Coding Policy and any plan document under which a member is entitled to Covered Services, the plan document will govern. If a conflict arises between a CPCP and any provider contract pursuant to which a provider participates in and/or provides Covered Services to eligible member(s) and/or plans, the provider contract will govern. “Plan documents” include, but are not limited to, Certificates of Health Care Benefits, benefit booklets, Summary Plan Descriptions, and other coverage documents. Blue Cross and Blue Shield of TX may use reasonable discretion interpreting and applying this policy to services being delivered in a particular case. Blue Cross and Blue Shield of TX has full and final discretionary authority for their interpretation and application to the extent provided under any applicable plan documents. Providers are responsible for submission of accurate documentation of services performed. Providers are expected to submit claims for services rendered using valid code combinations from Health Insurance Portability and Accountability Act approved code sets. Claims should be coded appropriately according to industry standard coding guidelines including, but not limited to: Uniform Billing Editor, American Medical Association, Current Procedural Terminology, CPT® Assistant, Healthcare Common Procedure Coding System, ICD-10 CM and PCS, National Drug Codes, Diagnosis Related Group guidelines, Centers for Medicare and Medicaid Services National Correct Coding Initiative Policy Manual, CCI table edits and other CMS guidelines. Claims are subject to the code edit protocols for services/procedures billed. Claim submissions are subject to claim review including but not limited to, any terms of benefit coverage, provider contract language, medical policies, clinical payment and coding policies as well as coding software logic. Upon request, the provider is urged to submit any additional documentation. Vitamin D Testing Policy Number: CPCPLAB003 Version 1.0 Approval Date: Sept. 13, 2024 Plan Effective Date: Jan. 1, 2025 (Blue Cross and Blue Shield of Texas Only) Description The plan has implemented certain lab management reimbursement criteria. Not all requirements apply to each product. Providers are urged to review Plan documents for eligible coverage for services rendered. Blue Cross and Blue Shield of Texas, a Division of Health Care Service Corporation, a Mutual Legal Reserve Company, an Independent Licensee of the Blue Cross and Blue Shield Association

Page 2

2 Reimbursement Information: 1. For individuals with an underlying disease or condition which is specifically associated with vitamin D deficiency or decreased bone density (see Note 1) or for individuals suspected of hypervitaminosis of Vitamin D, 25-hydroxyvitamin D serum testing may be reimbursable. 2. As part of the total 25-hydroxyvitamin D analysis, testing for D2 and D3 fractions of 25-hydroxyvitamin D may be reimbursable. 3. For individuals who have documented vitamin D deficiency, repeat testing for serum 25-hydroxyvitamin D at least 12 weeks after the initiation of vitamin D supplementation may be reimbursable with the following restrictions: a. Repeat testing for monitoring of supplementation therapy should not exceed 2 testing instances per year until the therapeutic goal is achieved. b. Once therapeutic range has been reached, annual testing, may be reimbursable. 4. For the evaluation or treatment of conditions that are associated with defects in vitamin D metabolism (see Note 2), 1,25-dihydroxyvitamin D serum testing may be reimbursable. 5. The following testing is not reimbursable: a. Measurement of serum 1,25-dihydroxyvitamin D to screen for vitamin D deficiency. b. Routine screening for vitamin D deficiency with serum testing in asymptomatic individuals and/or during general encounters Note 1: Indications that support reimbursement for serum measurement of 25-hydroxyvitamin D are as follows: A. Biliary cirrhosis and other specified disorders of the biliary tract B. Blind loop syndrome C. Celiac Disease D. Coronary artery disease in individuals where risk of disease progression is being considered against benefits of chronic vitamin D and calcium therapy E. Dermatomyositis F. Eating disorders G. Having undergone, or for those who have been scheduled for, bariatric procedures such as Roux-en-Y gastric bypass, sleeve gastrectomy, or biliopancreatic diversion with or without duodenal switch H. Hypercalcemia, hypocalcemia. or other disorders of calcium metabolism I. Hyperparathyroidism or hypoparathyroidism J. Individuals receiving hyperalimentation K. Intestinal malabsorption L. Liver cirrhosis

Page 3

3 M. Long term use of anticonvulsants, glucocorticoids and other medications known to lower vitamin D levels N. Malnutrition O. Myalgia and other myositis not specified P. Myopathy related to endocrine diseases Q. Neoplastic hematologic disorders R. Obesity S. Osteogenesis imperfecta T. Osteomalacia U. Osteopetrosis V. Osteoporosis W. Pancreatic steatorrhea X. Primary or miliary tuberculosis Y. Psoriasis Z. Regional enteritis AA. Renal, ureteral, or urinary calculus BB. Rickets CC. Sarcoidosis DD. Stage III-V Chronic Kidney Disease and End Stage Renal Disease EE. Systemic lupus erythematosus Note 2: Indications that support reimbursement for serum testing of 1,25- dihydroxyvitamin D are as follows: A. Disorders of calcium metabolism B. Familial hypophosphatemia C. Fanconi syndrome D. Hyperparathyroidism or hypoparathyroidism E. Individuals receiving hyperalimentation F. Neonatal hypocalcemia G. Osteogenesis imperfecta H. Osteomalacia I. Osteopetrosis J. Primary or miliary tuberculosis K. Renal, ureteral, or urinary calculus L. Rickets M. Sarcoidosis N. Stage III-V Chronic Kidney Disease and End Stage Renal Disease Procedure Codes The following is not an all-encompassing code list. The inclusion of a code does not guarantee it is a covered service or eligible for reimbursement. Codes 82306, 82652, 0038U

Page 4

4 References: ACOG. (2011). ACOG Committee Opinion No. 495: Vitamin D: Screening and supplementation during pregnancy. Obstet Gynecol, 118(1), 197-198. https://doi.org/10.1097/AOG.0b013e318227f06b Annema, W., Nowak, A., von Eckardstein, A., & Saleh, L. (2018). Evaluation of the new restandardized Abbott Architect 25-OH Vitamin D assay in vitamin D-insufficient and vitamin D-supplemented individuals. J Clin Lab Anal, 32(4), e22328. https://doi.org/10.1002/jcla.22328 Aspray, T. J., Bowring, C., Fraser, W., Gittoes, N., Javaid, M. K., Macdonald, H., Patel, S., Selby, P., Tanna, N., & Francis, R. M. (2014). National Osteoporosis Society vitamin D guideline summary. Age Ageing, 43(5), 592-595. https://doi.org/10.1093/ageing/afu093 Avenell, A., Bolland, M. J., & Grey, A. (2018). 25-Hydroxyvitamin D - Should labs be measuring it? Ann Clin Biochem, 4563218796858. https://doi.org/10.1177/0004563218796858 Awumey, E. M., Mitra, D. A., Hollis, B. W., Kumar, R., & Bell, N. H. (1998). Vitamin D metabolism is altered in Asian Indians in the southern United States: a clinical research center study. J Clin Endocrinol Metab, 83(1), 169-173. https://doi.org/10.1210/jcem.83.1.4514 Bolland, M. J., Grey, A., & Avenell, A. (2018). Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. https://doi.org/10.1016/s2213- 8587(18)30265-1 Camacho, P. M., Petak, S. M., Binkley, N., Diab, D. L., Eldeiry, L. S., Farooki, A., Harris, S. T., Hurley, D. L., Kelly, J., Lewiecki, E. M., Pessah-Pollack, R., McClung, M., Wimalawansa, S. J., & Watts, N. B. (2020). AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLINICAL PRACTICE GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS-2020 UPDATE. Endocr Pract, 26(Suppl 1), 1- 46. https://doi.org/10.4158/gl-2020-0524suppl CDC. (2017). VDSCP: Vitamin D Standardization-Certification Program. VDSCP: Vitamin D Standardization-Certification Program CDC. (2019). CDC Vitamin D Standardization-Certification Program. https://www.cdc.gov/labstandards/pdf/hs/CDC_Certified_Vitamin_D_Procedures- 508.pdf CDC. (2023). Facts: Falls Are Serious and Costly. https://www.cdc.gov/falls/facts.html Chapuy, M. C., Pamphile, R., Paris, E., Kempf, C., Schlichting, M., Arnaud, S., Garnero, P., & Meunier, P. J. (2002). Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int, 13(3), 257-264. https://doi.org/10.1007/s001980200023 Crowe, F. L., Thayakaran, R., Gittoes, N., Hewison, M., Thomas, G. N., Scragg, R., & Nirantharakumar, K. (2019). Non-linear associations of 25-hydroxyvitamin D

Page 5

5 concentrations with risk of cardiovascular disease and all-cause mortality: Results from The Health Improvement Network (THIN) database. J Steroid Biochem Mol Biol, 195, 105480. https://doi.org/10.1016/j.jsbmb.2019.105480 Dawson-Hughes, B. (2023, May 16). Causes of vitamin D deficiency and resistance. Wolters Kluwer. https://www.uptodate.com/contents/causes-of-vitamin-d- deficiency-and-resistance Dawson-Hughes, B. (2023, September 30, 2023). Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment. UptoDate. https://www.uptodate.com/contents/vitamin-d-deficiency-in-adults-definition- clinical-manifestations-and-treatment Dawson-Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (1997). Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med, 337(10), 670-676. https://doi.org/10.1056/nejm199709043371003 Dedeoglu, M., Garip, Y., & Bodur, H. (2014). Osteomalacia in Crohn's disease. Arch Osteoporos, 9, 177. https://doi.org/10.1007/s11657-014-0177-0 Ebell, M. H. (2019). Vitamin D Is Not Effective as Primary Prevention of Cardiovascular Disease or Cancer. Am Fam Physician, 100(6), 374. El Amrousy, D., El Ashry, H., Hodeib, H., & Hassan, S. (2021). Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial. J Clin Gastroenterol, 55(9), 815-820. https://doi.org/10.1097/MCG.0000000000001443 Fletcher, J., Cooper, S. C., Ghosh, S., & Hewison, M. (2019). The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management. Nutrients, 11(5). https://doi.org/10.3390/nu11051019 Glendenning, P., & Inderjeeth, C. A. (2012). Vitamin D: methods of 25 hydroxyvitamin D analysis, targeting at risk populations and selecting thresholds of treatment. Clin Biochem, 45(12), 901-906. https://doi.org/10.1016/j.clinbiochem.2012.04.002 Golden, N. H., & Abrams, S. A. (2014). Optimizing bone health in children and adolescents. Pediatrics, 134(4), e1229-1243. https://doi.org/10.1542/peds.2014- 2173 Goulart, R. A., & Barbalho, S. M. (2022). Can vitamin D induce remission in patients with inflammatory bowel disease? Ann Gastroenterol, 35(2), 140-149. https://doi.org/10.20524/aog.2022.0692 Granado-Lorencio, F., Blanco-Navarro, I., & Perez-Sacristan, B. (2016). Criteria of adequacy for vitamin D testing and prevalence of deficiency in clinical practice. Clin Chem Lab Med, 54(5), 791-798. https://doi.org/10.1515/cclm-2015-0781 Hao, L., Carson, J. L., Schlussel, Y., Noveck, H., & Shapses, S. A. (2020). Vitamin D deficiency is associated with reduced mobility after hip fracture surgery: a prospective study. The American Journal of Clinical Nutrition, 112(3), 613-618. https://doi.org/10.1093/ajcn/nqaa029 Holick, M. F. (2009). Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol, 19(2), 73-78. https://doi.org/10.1016/j.annepidem.2007.12.001 Holick, M. F. (2020). A call for action: standard of care guidelines to assess vitamin D status are needed for patients with hip fracture. Am J Clin Nutr, 112(3), 507-509. https://doi.org/10.1093/ajcn/nqaa202

Tags

Doxxly editorial guide

Vitamin D Testing: summary, contents and background

This guide helps you understand the scope of Vitamin D Testing before or alongside reading the original document. It is based on the catalogue record, credited creator, source, classification and topics shown on this page. It does not replace the original work and does not invent claims about passages that Doxxly cannot verify.

Summary and overview

Vitamin D Testing is a 8-page documentcredited to Mira H. Oakfield. Clinical Payment and Coding Policy CPCPLAB003, version 1.0, approved September 13, 2024, and effective January 1, 2025, for Blue Cross and Blue Shield of Texas only. Defines reimbursement criteria for 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D serum testing, including qualifying conditions, supplementation monitoring, and nonreimbursable screening. Repeat testing for documented deficiency may be reimbursable at least 12 weeks after supplementation begins, limited to two instances per year until the therapeutic goal is achieved, with annual testing thereafter. Lists procedure codes 82306, 82652, and 0038U, supporting references, and policy update history. Plan documents and provider contracts govern in the event of a conflict. It appears in the Medicine & Wellbeing collection, which groups it with other material that readers may use for comparison and further study.

The item can be approached in several ways. A reader looking for a quick orientation can begin with the free five-page preview, inspect the page structure and use the metadata to judge relevance. Someone undertaking deeper research can work through the complete file, search its indexed text, record useful page references and compare its treatment of Vitamin D testing, Laboratory reimbursement, Clinical payment and coding policy, Vitamin D deficiency, 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D, Blue Cross and Blue Shield of Texas with the related resources linked below.

Rather than reducing the work to a single claim, this page treats it as a source that should be read in context. The title, creator, publication source, licence and format all help explain what kind of evidence it may offer. Readers should distinguish the original author's statements from Doxxly's catalogue description, and should cite the original edition when using the material in academic, professional or published work.

Key topics and reader takeaways

The catalogue connects this document with Vitamin D testing, Laboratory reimbursement, Clinical payment and coding policy, Vitamin D deficiency, 25-hydroxyvitamin D, 1, 25-dihydroxyvitamin D, Blue Cross and Blue Shield of Texas. These terms offer practical entry points rather than a substitute for close reading. Start by identifying the definitions, examples, arguments, tables or visual explanations attached to each topic. Then note where the creator draws connections, makes distinctions or moves from background material to a conclusion, recommendation, calculation or narrative development.

A useful reading method is to separate description from interpretation. First record what the item actually presents: names, headings, figures, formulas, quotations or stated propositions. Next consider why those details matter within the whole work. Finally compare them with another source from the same subject area. This process helps turn a long digital file into evidence that can be evaluated rather than merely skimmed.

Table of contents and reading guide

The following is an editorial content guide based on the verified catalogue topics. It is not represented as the original author's formal table of contents. Use it to organise notes while moving through the 8 pages in the player.

  1. Part 1

    Vitamin D testing

    Use this section of the reading guide to identify how Vitamin D testing appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  2. Part 2

    Laboratory reimbursement

    Use this section of the reading guide to identify how Laboratory reimbursement appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  3. Part 3

    Clinical payment and coding policy

    Use this section of the reading guide to identify how Clinical payment and coding policy appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  4. Part 4

    Vitamin D deficiency

    Use this section of the reading guide to identify how Vitamin D deficiency appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  5. Part 5

    25-hydroxyvitamin D

    Use this section of the reading guide to identify how 25-hydroxyvitamin D appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  6. Part 6

    1

    Use this section of the reading guide to identify how 1 appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  7. Part 7

    25-dihydroxyvitamin D

    Use this section of the reading guide to identify how 25-dihydroxyvitamin D appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

  8. Part 8

    Blue Cross and Blue Shield of Texas

    Use this section of the reading guide to identify how Blue Cross and Blue Shield of Texas appears in Vitamin D Testing, note important terms, and connect the subject to the wider purpose of the work.

When a heading in the original differs from this guide, follow the original heading in your citation. Page numbers can also vary between editions. Doxxly's direct page field is useful for navigation, but formal references should include the title, creator, source and edition details available in the file itself.

About Mira H. Oakfield

Doxxly credits Mira H. Oakfield as the author or creator of Vitamin D Testing. This page does not add an unverified biography, job title or institutional affiliation. The attribution is preserved so readers can distinguish the creator from the hosting library and follow the original record when an external author link is available.

Author context matters because a work reflects a particular purpose, audience and point of view. Before relying on the material, consider what the creator set out to explain, when the source was produced and whether later research or revised guidance should also be consulted. For literature and philosophy, compare translations and editions; for technical material, check whether a newer version has superseded the one shown here.

About the source organisation

The recorded source for this item is bcbstx.com. Doxxly provides access and discovery tools but does not claim to be the original publisher unless explicitly stated. Source links, creator attribution and the recorded Publicly available file collected for editorial review licence are displayed to help readers assess provenance and permitted use.

Provenance is especially important for reports, standards, presentations and working spreadsheets. Check the original source for amendments, supporting files and current policy. A trustworthy research workflow keeps the source URL with any notes or downloaded copy, verifies important figures against the original, and avoids treating an archived document as automatically current.

Visit bcbstx.com

How to read and use this document

Begin with the title and opening pages, then use the guide above to decide whether to read sequentially or move to a particular topic. The Doxxly player provides previous and next navigation, a direct page field, zoom steps, fit-to-width and fit-to-page modes, rotation and fullscreen. These controls are useful when a page contains small type, a wide table, an image, a scanned layout or a dense sequence of notes.

The first five pages are open to every visitor. A plan unlocks the complete item and full-document search. Search is best used for distinctive names, technical terms or short phrases; broad words can produce too many possible contexts. When you find a useful passage, read the surrounding pages so that a sentence, chart or formula is not separated from its explanation.

If downloading is enabled, members can obtain the original PDF file. Keep the original format when formulas, slide sequencing, pagination or layout carries meaning. Respect the Publicly available file collected for editorial review terms displayed on this page, and use the rights-report link if you believe the attribution or availability needs review.

Research questions to consider

As you read Vitamin D Testing, ask which audience the creator addresses, what problem or idea organises the work, what evidence is presented, and which assumptions remain unstated. Note whether important terms are defined consistently and whether examples represent a broader pattern or a narrow case. For quantitative material, record units, time periods, formulas and data sources. For interpretive material, separate the creator's language from your own summary.

A second set of questions concerns relevance today. Which parts remain durable, which depend on their historical or institutional setting, and what would need confirmation from a newer source? Following the tags and the Medicine & Wellbeing collection can reveal useful comparisons. Agreement between sources can strengthen confidence, while disagreement can point to changing definitions, methods, evidence or priorities.

Finally, decide what you need from the item: background knowledge, a quotation, a worked example, a model, a visual explanation or a starting bibliography. That purpose should guide the depth of reading and the notes you keep. Doxxly helps locate and navigate the source; careful interpretation remains the reader's responsibility.

Explore more Medicine & Wellbeing resources

Frequently asked questions about Vitamin D Testing

Practical answers about reading, downloading and understanding this document on Doxxly.

More in Medicine & Wellbeing